Intuitive Surgical 8-K

Summary

Stockholder approvals and expanded share-repurchase authorization. At the 4/30/2026 annual meeting, stockholders approved the amended incentive plan, which adds 5.0M shares to its reserve and extends its term to 1/29/2036. The Board also increased the aggregate repurchase authorization to $5.0B, including amounts remaining under prior authorizations.

Key Figures

• Repurchase authorization: up to $5.0B in aggregate; repurchases may be made over time, are not required, and are expected to be funded with cash, cash equivalents and investments.
• Incentive plan: shares reserved for awards increased from 120.35M to 125.35M; term extended to 1/29/2036. The amendment also further specifies treatment of awards in a change in control.
• All director nominees were elected; advisory say-on-pay was approved, the auditor’s appointment was ratified, and the amended incentive plan was approved.

Investor Takeaways

• Actual repurchases and their timing will depend on market conditions; the company may suspend or discontinue them.